Genus (LON:GNS) Announces Quarterly Earnings Results

Genus (LON:GNS) posted its earnings results on Thursday. The company reported GBX 110.30 EPS for the quarter, Digital Look Earnings reports. Genus had a return on equity of 9.70% and a net margin of 7.07%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Trading Down 3.3%

Shares of LON:GNS traded down GBX 74 during midday trading on Thursday, reaching GBX 2,160. The company’s stock had a trading volume of 543,824 shares, compared to its average volume of 769,729. The company has a quick ratio of 1.08, a current ratio of 2.25 and a debt-to-equity ratio of 51.73. The firm has a market cap of £1.43 billion, a price-to-earnings ratio of 30.42, a price-to-earnings-growth ratio of 2.87 and a beta of 0.90. The business has a 50 day moving average price of GBX 2,223.11 and a 200 day moving average price of GBX 2,382.24. Genus has a 1 year low of GBX 1,943 and a 1 year high of GBX 3,220.

Key Headlines Impacting Genus

Here are the key news stories impacting Genus this week:

• Positive Sentiment: £60 million share buyback: Genus launched a repurchase programme, signalling management’s confidence in the company’s growth prospects and potentially supporting earnings per share by reducing the share count. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: Profit growth and lower leverage: FY26 pretax profit increased, while the company reduced leverage following developments involving its China joint venture. These factors strengthen the balance sheet and provide capacity for shareholder returns. Genus boosts profits, cuts leverage and launches £60m buyback after China JV
• Positive Sentiment: Analyst support: Berenberg reaffirmed its “buy” rating and set a GBX 3,350 price target, implying substantial upside from the current trading level. Investors Chronicle also described the recent weakness as a potential buying opportunity. Genus share price weakness offers buying opportunity
• Neutral Sentiment: Genus reported quarterly EPS of GBX 110.30, with a 7.07% net margin and 9.70% return on equity. The results indicate profitability, but investors focused more heavily on forward guidance and revenue performance. Genus earnings results
• Negative Sentiment: Moderating FY27 growth and revenue miss: Genus forecast only moderate operating-profit growth for FY27 and missed revenue expectations. The cautious outlook raises concerns about near-term demand and earnings momentum, prompting the sell-off despite the improved FY26 profit result. Genus Shares Fall 7% as Company Forecasts Moderate FY27 Operating Profit Growth

Insider Transactions at Genus

In related news, insider Celia Baxter purchased 2,336 shares of the business’s stock in a transaction on Friday, June 26th. The shares were bought at an average price of GBX 2,140 per share, with a total value of £49,990.40. Insiders own 0.71% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 3,350 price objective on shares of Genus in a research note on Thursday. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of GBX 3,216.67.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.